SteelPeak Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-300
Closed -$22K 284
2020
Q1
$22K Buy
+300
New +$20.7K ﹤0.01% 240

Other funds holding GILD

SteelPeak Wealth's GILD Position: Q2 2026 in Review

SteelPeak Wealth reduced its Gilead Sciences (GILD) stake by 98% in Q2 2026, selling an estimated $16.2M and leaving 2,493 shares worth $315K. The position accounts for 0.01% of the portfolio, ranked #513.

SteelPeak Wealth first reported a position in GILD in Q4 2019 and has held it in 23 quarters since. The position peaked at $17.4M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • SteelPeak Wealth held 2,493 shares of Gilead Sciences worth $315K as of Q2 2026.
  • SteelPeak Wealth sold 122,710 Gilead Sciences shares in Q2 2026, an estimated $16.2M.
  • Gilead Sciences made up 0.01% of SteelPeak Wealth's portfolio in Q2 2026, its #513 holding.
  • SteelPeak Wealth first reported a position in Gilead Sciences in Q4 2019 and has held it in 23 quarters since.
  • SteelPeak Wealth's Gilead Sciences position peaked at $17.4M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.